Nodular bronchiectatic Mycobacterium avium complex pulmonary disease: Natural course on serial computed tomographic scans

Annals of the American Thoracic Society

Volumn 10, Issue 4, 2013, Pages 299-306

  Lee, Geewon ^a,b   Lee, Kyung Soo ^a   Moon, Jung Won ^a   Koh, Won Jung ^a   Jeong, Byeong Ho ^a   Jeong, Yeon Joo ^b   Kim, Hak Jin ^b   Woo, Sookyoung ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Bronchiectasis; Computed tomography; Mycobacterium avium; Natural history

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ETHAMBUTOL; RIFAMPICIN;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LONG TERM CARE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; PREDICTIVE VALUE; RETROSPECTIVE STUDY;

AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIECTASIS; CLARITHROMYCIN; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; MULTIVARIATE ANALYSIS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RIFAMPIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883444000     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201303-062OC     Document Type: Article

References (18)

1. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL.Nontuberculous mycobacterial disease prevalence and riskfactors: a changing epidemiology. Clin Infect Dis 2009;49:e124-e129.
2. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence ofpulmonary non-tuberculous mycobacteria in Ontario, 1997-2003.Thorax 2007;62:661-666.
3. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al.Nontuberculous mycobacterial lung disease prevalence at fourintegrated health care delivery systems. Am J Respir Crit Care Med2010;182:970-976.
4. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J,Wardlaw AJ, Pavord ID. Clinical, radiologic, and induced sputumfeatures of chronic obstructive pulmonary disease in nonsmokers:a descriptive study. Am J Respir Crit Care Med 2002;166:1078-1083.
5. Saleeb P, Olivier KN. Pulmonary nontuberculous mycobacterialdisease: new insights into risk factors for susceptibility, epidemiology,and approaches to management in immunocompetent andimmunocompromised patients. Curr Infect Dis Rep 2010;12:198-203.
6. Field SK, Cowie RL. Lung disease due to the more commonnontuberculous mycobacteria. Chest 2006;129:1653-1672.
7. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, GordinF, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATSMycobacterial Diseases Subcommittee; American Thoracic Society;Infectious Disease Society of America. An official ATS/IDSAstatement: diagnosis, treatment, and prevention of nontuberculousmycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
8. Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, Shin SJ, KwonOJ. Clinical significance of the differentiation between Mycobacteriumavium and Mycobacterium intracellulare in M. avium complex lungdisease. Chest 2012;142:1482-1488.
9. Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ. Standardizedcombination antibiotic treatment of Mycobacterium avium complexlung disease. Yonsei Med J 2010;51:888-894.
10. Leber A, Marras TK. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. EurRespir J 2011;37:1158-1165.
11. Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, Kwon OJ.High-resolution CT findings of Mycobacterium aviumintracellularecomplex pulmonary disease: correlation withpulmonary function test results. AJR Am J Roentgenol 2008;191:1070.
12. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification ofmycobacteria by PCR-restriction fragment length polymorphism ofthe rpoB gene. J Clin Microbiol 2000;38:2966-2971.
13. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, RemyJ. Fleischner Society: glossary of terms for thoracic imaging.Radiology 2008;246:697-722.
14. Kim HS, Lee KS, Koh WJ, Jeon K, Lee EJ, Kang H, Ahn J. Serial CTfindings of Mycobacterium massiliense pulmonary diseasecompared with Mycobacterium abscessus disease after treatmentwith antibiotic therapy. Radiology 2012;263:260-270.
15. Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S.Markers indicating deterioration of pulmonary Mycobacteriumavium-intracellulare infection. Am J Respir Crit Care Med 1999;160:1851-1855.
16. Kuroishi S, Nakamura Y, Hayakawa H, Shirai M, Nakano Y, Yasuda K,Suda T, Nakamura H, Chida K. Mycobacterium avium complexdisease: prognostic implication of high-resolution computedtomography findings. Eur Respir J 2008;32:147-152.
17. Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR.Pulmonary nontuberculous mycobacterial infections: antibiotictreatment and associated costs. Respir Med 2009;103:1448-1455.
18. Liippo KK, Kulmala K, Tala EO. Focusing tuberculosis contact tracingby smear grading of index cases. Am Rev Respir Dis 1993;148:235-236.